Patents
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
03/2009
03/12/2009WO2009030715A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
03/12/2009US20090069332 Novel pyridazine derivatives and medicines containing the same as effective ingredients
03/12/2009US20090069303 Phthalazinone derivatives
03/12/2009US20090069297 protein kinase inhibnitors such as N-(4-((7-(methyloxy)-1,5-naphthyridin-4-yl)oxy)phenyl)-4-phenyl-1-phthalazinamine, for influencing the process of cell cycle and cell proliferation to treat cancer; anticarcinogenic agents
03/12/2009US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds
03/12/2009CA2698486A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
03/12/2009CA2698341A1 Gamma secretase modulators
03/11/2009EP1319659B1 Triazinones and medicinal use thereof
03/11/2009CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same
03/10/2009US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity
03/05/2009WO2009027730A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009WO2009027450A1 Novel bradykinin b1-antagonists
03/05/2009WO2008062276A3 Acetylene derivatives as stearoyl coa desaturase inhibitors
03/05/2009US20090061143 Organic compound for recording layer for high speed recording of information and optical recording medium including the same
03/05/2009CA2697971A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009CA2697946A1 New bradykinin b1-antagonists
03/04/2009EP2029551A2 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
03/04/2009CN101379042A Substituted cinnoline derivatives as GABAA-receptor modulators and method for their synthesis
03/03/2009US7498436 Substituted hydroxyethylamines
03/03/2009US7498323 Spiro-piperidine compounds and medicinal use thereof
02/2009
02/26/2009WO2009024221A1 6-thioxo-pyridazine derivatives
02/26/2009WO2007014226A3 Compounds for the treatment of neurodegeneration and stroke
02/26/2009US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
02/26/2009US20090054444 2(R)-2-(4-cyclopropanesulfonylphenyl)-N-(1-methylpyrazol-3-yl)-3-((R)-3-oxocyclopentyl)propionamide, useful in the prophylaxis and treatment of hyperglycemia and diabetes; hypoglycemic and antidiabetic agents
02/26/2009US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands
02/26/2009US20090053826 Electropolymerisable monomers that are soluble in aqueous solution and electroactive probes that can be obtained with such monomers
02/26/2009CA2696472A1 6-thioxopyridazine derivatives
02/25/2009CN100464189C Magnetic separating direct chemical illuminating reagent and testing method using the same reagent
02/24/2009US7494990 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
02/19/2009US20090048259 Phthalazine compounds, compositions and methods of use
02/19/2009US20090048226 Inhibitors of caspases
02/19/2009DE102007038957A1 6-Thioxo-pyridazinderivate 6-thioxo-pyridazine derivatives
02/18/2009EP2024337A1 Solid dosage formulations of hydralazine compounds
02/17/2009US7491741 Diaminopropionic acid derivatives
02/17/2009US7491722 Pyridazin-3(2H)-one derivatives
02/12/2009US20090042892 Cetp Inhibitors
02/12/2009US20090042888 Prostaglandin endoperoxide H synthase biosynthesis inhibitors
02/11/2009EP1228063B1 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
02/10/2009US7488739 platelet aggregation inhibitors; anti-platelet agent with a high safety profile with a smaller adverse bleeding effect; P2Y12 inhibitor; (2S)-2-({[7-(cyclohexylamino)-1-cyclopentyl-6-fluoro-4-oxo-1,4-dihydroquinolin-3-yl]carbonyl}amino)butanedioic acid
02/05/2009WO2009016286A2 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
02/05/2009WO2007003521A3 Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
02/05/2009US20090036454 Compounds and Uses Thereof
02/05/2009US20090035267 Acyclic, pyridazinone-derived hepatitis c serine protease inhibitors
02/05/2009CA2691866A1 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
02/04/2009CN100457735C Therapeutic agents useful for treating pain
02/03/2009US7485643 Bicyclic inhibitors of MEK and methods of use thereof
02/03/2009US7485642 Administering levosimendan or a salt thereof
02/03/2009CA2382435C Novel herbicidally active phenyl-substituted heterocycles
01/2009
01/29/2009US20090030008 Piperazine derivatives and their use as therapeutic agents
01/29/2009US20090030000 Antiviral agents
01/29/2009US20090029996 Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors
01/29/2009US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors
01/29/2009US20090029985 Pyridazine compounds and methods
01/29/2009US20090028815 Diazabenzo[De]anthracen-3-one Compounds and Methods for Inhibiting Parp
01/28/2009EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
01/28/2009CN101356159A Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2H)-isoquinolones and methods of use thereof
01/27/2009CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
01/22/2009US20090023738 Diaminopyrimidines as modulators of the ep2 receptor
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/21/2009EP2017266A1 Pyridazine derivatives and medicines containing the same as effective ingredients
01/21/2009EP0958291B1 3-heterocyclyl-substituted benzoyl derivatives
01/15/2009US20090018116 Therapeutic Compounds
01/15/2009US20090018112 Compounds and Uses Thereof
01/15/2009US20090018056 Heteroarylcarbamoylbenzene derivatives
01/14/2009EP1532120B1 Phenylpyridazine derivatives as ligands for gaba receptors
01/14/2009EP1478363B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
01/08/2009WO2009004356A1 Phthalazinone derivatives as inhibitors of parp-1
01/08/2009US20090012084 7-Ethoxy-4-[(2-fluoro-4-methyl-phenyl)amino]-6-(4-methylpiperazin-1-yl)cinnoline-3-carboxamide, having colony stimulating factor 1 receptor (CSF-1R) kinase inhibitory activity, used as anticarcinogenic agents
01/08/2009CA2691459A1 Phthalazinone derivatives as inhibitors of parp-1
01/01/2009US20090005383 Thyroid hormone analogs
12/2008
12/31/2008WO2008121877A3 Cftr inhibitor compounds and uses thereof
12/31/2008EP2007735A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
12/31/2008CN101333187A Novel PI3K enzyme inhibitors and uses thereof
12/30/2008US7470690 4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder
12/30/2008US7470687 Aryl oximes
12/30/2008CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
12/30/2008CA2223720C Novel uses for thyroid hormones or thyroid hormone-like compounds
12/25/2008US20080318960 PAR2-modulating compounds and their use
12/25/2008US20080318959 using 3-amino-5-ethyl-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide
12/25/2008US20080318958 New utilities of tricyclic compounds
12/24/2008WO2008156208A1 5-phenyl-3-pyridazinone derivative
12/24/2008WO2007117653A3 Cdk9-pi3k-akt inhibitors for cancer treatment
12/24/2008EP2004607A2 New compounds
12/24/2008EP2004595A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
12/24/2008EP1937651B1 Nnrt inhibitors
12/24/2008CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/24/2008CN100445272C Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity
12/23/2008CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity
12/18/2008WO2008080056A3 Pyridazinones and furan-containing compounds
12/18/2008US20080308770 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors
12/17/2008EP2001851A2 Amide derivatives and their application for the treament of g protein related diseases
12/17/2008CN101326167A Pyridiazinone derivatives for tumour treatment
12/17/2008CN100443474C New pyridazin-3(2h)-one derivatives
12/16/2008US7465795 Compounds and uses thereof
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008DE102007025717A1 Arylether-pyridazinonderivate Aryl ether pyridazinone derivatives
12/10/2008CN101321731A Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
12/09/2008US7462613 Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
12/09/2008CA2321254C Pyradazine derivatives having inhibitory activity against interleukin-1.beta. production
12/04/2008WO2008146914A1 Heterocyclic compound
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 85